Cell Surface Markers Detection Market to Grow with a CAGR of 7.25% through 2028
Rising prevalence of chronic diseases and increasing
healthcare expenditure are factors driving the global Cell Surface Markers
Detection market in the forecast period 2024-2028
According to TechSci Research report, “Cell Surface
Markers Detection Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Cell
Surface Markers Detection Market stood at USD 9.74 billion in 2022 and is
anticipated to grow with a CAGR of 7.25% in the forecast period, 2024-2028. The global cell surface markers detection market has witnessed
substantial growth in recent years, and it continues to expand at a rapid pace.
This remarkable progress can be attributed to a variety of market drivers that
are shaping the industry's landscape. Cell surface markers play a crucial role
in understanding and characterizing different cell types in biological research
and clinical diagnostics. One of the primary drivers of the cell surface markers
detection market is the growing demand for personalized medicine. Personalized
medicine involves tailoring medical treatments to an individual's unique
genetic and molecular profile. Detecting and characterizing cell surface
markers is essential for identifying disease markers, predicting treatment
responses, and developing targeted therapies. As healthcare providers and
pharmaceutical companies increasingly focus on personalized medicine, the
demand for cell surface marker detection technologies is expected to rise
significantly. The
field of immuno-oncology has witnessed substantial advancements in recent
years. Cell surface markers are crucial for understanding the immune system's
response to cancer cells. The development of immunotherapies and immune
checkpoint inhibitors, such as PD-1 and PD-L1 inhibitors, relies heavily on
cell surface marker detection to assess the efficacy of treatments and predict
patient outcomes. This expanding application in cancer research and therapy
drives the growth of the cell surface markers detection market.
The global burden of chronic diseases,
including cancer, autoimmune disorders, and cardiovascular diseases, continues
to rise. Cell surface markers are essential in diagnosing, monitoring, and
studying these conditions. As the prevalence of chronic diseases increases,
there is a growing need for advanced detection methods to understand disease
mechanisms, develop therapeutic interventions, and track treatment responses.
This trend is a significant driver for the cell surface markers detection
market. Governments, academic institutions, and private enterprises are
investing heavily in life sciences research. This includes funding for basic
research, drug development, and clinical trials. As cell surface markers
detection is central to many areas of life sciences research, including
immunology, stem cell biology, and neuroscience, the market is positively
influenced by these investments.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Cell Surface Markers Detection Market”
The Global Cell Surface Markers Detection Market is segmented into product, application and company
Based on product, the Flow Cytometry segment has
emerged as the predominant market leader. Flow cytometry has found increasing use in clinical
diagnostics and personalized medicine, further driving its adoption. It is
employed in cancer diagnosis, immunophenotyping, and monitoring of infectious
diseases. Flow cytometry is not limited to cell surface marker detection; it
can be used for other applications such as apoptosis analysis, cell cycle
analysis, and cell sorting. This versatility makes it a cost-effective
investment for laboratories and research institutions. Ongoing
advancements in flow cytometry technology have led to improved resolution,
higher-dimensional analysis, and greater ease of use, making it an attractive
choice for researchers and clinicians.
Based on region, North America segment is expected to
grow during the forecast period. Collaboration between academic
institutions, government agencies, and private companies is common in North
America. These partnerships foster innovation and help accelerate the
development of new techniques and products for cell surface markers detection.
Such collaborations are essential in meeting the evolving needs of the research
and clinical communities.
The Asia Pacific region is experiencing rapid market
growth. Asia Pacific’s well-established infrastructure ensures
that researchers and clinicians have easy access to the latest cell surface
markers detection technologies. This accessibility, along with a robust
distribution network, promotes the adoption of these technologies throughout
the region.
Major companies operating in Global Cell Surface
Markers Detection Market are:
- Becton, Dickinson and Company
- Nihon Kohden Corporation
- Sysmex Corporation
- Thermo Fisher Scientific inc.
- Nexcelom Bioscience LLC
- Beckman Coulter Inc.
- Qiagen NV
- IVD Medical Holding Limited (Immucor
Inc.)
- Agilent Technologies Inc.
- Luminex Corporation
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The global cell surface markers detection market is
poised for continued growth, primarily driven by the increasing demand for
personalized medicine, expanding applications in immuno-oncology, technological
advancements, the rising prevalence of chronic diseases, increased investment
in life sciences research, and the expanding aging population. As technology
continues to advance and our understanding of cell surface markers deepens,
this market is expected to play an increasingly pivotal role in the diagnosis
and treatment of a wide range of diseases, ultimately improving healthcare
outcomes for patients worldwide.,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Cell Surface Markers Detection Market By Product
(Flow Cytometry, Hematology analysers, Cell Imaging Systems, Reagents and Kits,
Other), By Application (Disease Diagnosis And Identifications, Research And
Drug Discovery, Others), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Cell Surface Markers Detection Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Cell Surface Markers Detection Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com